More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor.
Publication
, Journal Article
Tantry, US; Jeong, Y-H; Gurbel, PA
Published in: JACC Cardiovasc Interv
August 28, 2017
Duke Scholars
Published In
JACC Cardiovasc Interv
DOI
EISSN
1876-7605
Publication Date
August 28, 2017
Volume
10
Issue
16
Start / End Page
1659 / 1661
Location
United States
Related Subject Headings
- Ticagrelor
- Purinergic P2Y Receptor Antagonists
- Prospective Studies
- Prasugrel Hydrochloride
- Inflammation
- Humans
- Endothelial Progenitor Cells
- Diabetes Mellitus
- Cross-Over Studies
- Cardiovascular System & Hematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Tantry, U. S., Jeong, Y.-H., & Gurbel, P. A. (2017). More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor. JACC Cardiovasc Interv, 10(16), 1659–1661. https://doi.org/10.1016/j.jcin.2017.06.014
Tantry, Udaya S., Young-Hoon Jeong, and Paul A. Gurbel. “More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor.” JACC Cardiovasc Interv 10, no. 16 (August 28, 2017): 1659–61. https://doi.org/10.1016/j.jcin.2017.06.014.
Tantry US, Jeong Y-H, Gurbel PA. More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor. JACC Cardiovasc Interv. 2017 Aug 28;10(16):1659–61.
Tantry, Udaya S., et al. “More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor.” JACC Cardiovasc Interv, vol. 10, no. 16, Aug. 2017, pp. 1659–61. Pubmed, doi:10.1016/j.jcin.2017.06.014.
Tantry US, Jeong Y-H, Gurbel PA. More Evidence for Non-P2Y12-Mediated Effects of Ticagrelor. JACC Cardiovasc Interv. 2017 Aug 28;10(16):1659–1661.
Published In
JACC Cardiovasc Interv
DOI
EISSN
1876-7605
Publication Date
August 28, 2017
Volume
10
Issue
16
Start / End Page
1659 / 1661
Location
United States
Related Subject Headings
- Ticagrelor
- Purinergic P2Y Receptor Antagonists
- Prospective Studies
- Prasugrel Hydrochloride
- Inflammation
- Humans
- Endothelial Progenitor Cells
- Diabetes Mellitus
- Cross-Over Studies
- Cardiovascular System & Hematology